| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.46 |
0.1 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
0.04 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.1 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.1 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.18 |
0.6 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.02 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.2 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.2 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |